Space can be a frontier—in a non-Star Trek way.
Like gold miners of old, some technologists see opportunities for disruption and commercialization beyond our atmosphere. NASA’s annual International Space Apps Challenge, coming up this weekend, will be a chance for... Read more »
The U.S. saw slightly fewer businesses created last year, but there’s a silver lining: the poorer numbers nationwide likely indicate that a stronger job market relieved some of the pressure on people to start companies out of necessity.
That’s among the... Read more »
This spring, New York seems to want to prove it is a not-so-secret garden for technology.
A study released last week paints a picture of a city with a chance to grow more rapidly—if it works harder at embracing technology.
Several... Read more »
For the past two years, Xconomy has held an invitation-only event in the heart of California wine country with a general focus on the economy, emerging technology, competitiveness, and jobs—and spanning the range of topics we cover, from information technology to... Read more »
When David Schenkein left Genentech to lead Agios Pharmaceuticals in 2009, part of the draw was the fact that the Cambridge, MA-based startup was positioning itself as a trailblazer in a raw field of oncology—cancer metabolism. The idea, essentially, was... Read more »
Dear Citizens of 2061,
If you’re reading this, congratulations. You’ve survived the first half of the 21st century, and you’ve evidently still got computers, libraries, virtual-reality visors, or some kind of communications system that enabled you to dig up these old... Read more »
Big ambitions, and creative, risk-sharing deals—two concepts that often go hand in hand with biotech. They’re also the themes of two of the big stories on the East Coast this week. Those and plenty more below.
—Drug discovery is expensive, time-consuming... Read more »
Last month, a startup called WellTrackOne—one of the most recent grads to come out of Blueprint Health, the New York healthtech accelerator—bagged a $1.5 million Series A round led by Easton Capital. That nascent company is now on track to... Read more »
Even in the brazen world of biotech, Berg Pharma stands out for its grand ambitions.
Co-founder Carl Berg, the Silicon Valley real estate billionaire, says his namesake Framingham, MA-based startup is capable of “revolutionizing” healthcare. President and chief technology officer... Read more »